Literature DB >> 20727534

Cyclophosphamide for rapid-onset obesity, hypothalamic dysfunction, hypoventilation, and autonomic dysregulation syndrome.

Ido Paz-Priel1, David W Cooke, Allen R Chen.   

Abstract

Patients with rapid-onset obesity, hypothalamic dysfunction, hypoventilation, autonomic dysregulation, and neural crest tumor syndrome have poor long-term outcomes. We report a patient who was treated successfully with high-dose cyclophosphamide immunoablation. This experience offers a novel therapeutic approach and an indirect insight into the underlying pathogenesis of this syndrome.
Copyright © 2011 Mosby, Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20727534      PMCID： PMC3976575          DOI： 10.1016/j.jpeds.2010.07.006

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


  13 in total

Review 1.  High-dose cyclophosphamide for autoimmunity and alloimmunity.

Authors:  Robert A Brodsky
Journal:  Immunol Res       Date:  2010-07       Impact factor: 2.829

Review 2.  On the use of causal criteria.

Authors:  D L Weed
Journal:  Int J Epidemiol       Date:  1997-12       Impact factor: 7.196

Review 3.  High-dose therapy for autoimmune neurologic diseases.

Authors:  Daniel B Drachman; Robert A Brodsky
Journal:  Curr Opin Oncol       Date:  2005-03       Impact factor: 3.645

Review 4.  Late-onset central hypoventilation with hypothalamic dysfunction: a distinct clinical syndrome.

Authors:  E S Katz; S McGrath; C L Marcus
Journal:  Pediatr Pulmonol       Date:  2000-01

5.  Idiopathic hypothalamic dysfunction: a paraneoplastic syndrome?

Authors:  R Ouvrier; K Nunn; T Sprague; C McLean; S Arbuckle; I Hopkins; K North
Journal:  Lancet       Date:  1995-11-11       Impact factor: 79.321

6.  Endocrine manifestations of the rapid-onset obesity with hypoventilation, hypothalamic, autonomic dysregulation, and neural tumor syndrome in childhood.

Authors:  Pierre Bougnères; Letitia Pantalone; Agnès Linglart; Anya Rothenbühler; Catherine Le Stunff
Journal:  J Clin Endocrinol Metab       Date:  2008-07-15       Impact factor: 5.958

7.  Idiopathic hypothalamic dysfunction with dilated unresponsive pupils: report of two cases.

Authors:  K N North; R A Ouvrier; C A McLean; I J Hopkins
Journal:  J Child Neurol       Date:  1994-07       Impact factor: 1.987

8.  Hypothalamic dysfunction associated with neuroblastoma: evidence for a new Paraneoplastic syndrome?

Authors:  Nicolas Sirvent; Etienne Bérard; Pascal Chastagner; François Feillet; Karin Wagner; Danièle Sommelet
Journal:  Med Pediatr Oncol       Date:  2003-05

9.  High dose cyclophosphamide performs better than monthly dose cyclophosphamide in quality of life measures.

Authors:  K B Dussán; L Magder; R A Brodsky; R J Jones; M Petri
Journal:  Lupus       Date:  2008-12       Impact factor: 2.911

10.  Rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation presenting in childhood.

Authors:  Diego Ize-Ludlow; Juliette A Gray; Mark A Sperling; Elizabeth M Berry-Kravis; Jeff M Milunsky; I Sadaf Farooqi; Casey M Rand; Debra E Weese-Mayer
Journal:  Pediatrics       Date:  2007-07       Impact factor: 7.124
View more
  12 in total

Review 1.  Autoimmune encephalitis in children.

Authors:  Thaís Armangue; Mar Petit-Pedrol; Josep Dalmau
Journal:  J Child Neurol       Date:  2012-08-29       Impact factor: 1.987

Review 2.  Review of paraneoplastic syndromes in children.

Authors:  Grace My Ma; Jeanne S Chow; George A Taylor
Journal:  Pediatr Radiol       Date:  2019-03-16

3.  Improved Behavior and Neuropsychological Function in Children With ROHHAD After High-Dose Cyclophosphamide.

Authors:  Lisa A Jacobson; Shruti Rane; Lisa J McReynolds; Diana A Steppan; Allen R Chen; Ido Paz-Priel
Journal:  Pediatrics       Date:  2016-06-16       Impact factor: 7.124

4.  ROHHAD Syndrome: Reasons for Diagnostic Difficulties in Obesity.

Authors:  Pınar Kocaay; Zeynep Şıklar; Emine Çamtosun; Tanıl Kendirli; Merih Berberoğlu
Journal:  J Clin Res Pediatr Endocrinol       Date:  2014-12

5.  Rapid-Onset Obesity with Hypoventilation, Hypothalamic, Autonomic Dysregulation, and Neuroendocrine Tumors (ROHHADNET) Syndrome: A Systematic Review.

Authors:  Jiwon M Lee; Jaewon Shin; Sol Kim; Heon Yung Gee; Joon Suk Lee; Do Hyeon Cha; John Hoon Rim; Se-Jin Park; Ji Hong Kim; Ahmet Uçar; Andreas Kronbichler; Keum Hwa Lee; Jae Il Shin
Journal:  Biomed Res Int       Date:  2018-11-21       Impact factor: 3.411

6.  Natural history of ROHHAD syndrome: development of severe insulin resistance and fatty liver disease over time.

Authors:  Abdel Wahab Jalal Eldin; Dilara Tombayoglu; Laura Butz; Alison Affinati; Rasimcan Meral; Mehmet Selman Ontan; Kelly Walkovich; Maria Westerhoff; Jeffrey W Innis; Neehar D Parikh; Elif A Oral
Journal:  Clin Diabetes Endocrinol       Date:  2019-07-09

7.  Case Report: COVID-19-Associated ROHHAD-Like Syndrome.

Authors:  Irina N Artamonova; Natalia A Petrova; Natalia A Lyubimova; Natalia Yu Kolbina; Alexander V Bryzzhin; Alexander V Borodin; Tatyana A Levko; Ekaterina A Mamaeva; Tatiana M Pervunina; Elena S Vasichkina; Irina L Nikitina; Anna M Zlotina; Alexander Yu Efimtsev; Mikhail M Kostik
Journal:  Front Pediatr       Date:  2022-03-31       Impact factor: 3.418

8.  ZSCAN1 Autoantibodies Are Associated with Pediatric Paraneoplastic ROHHAD.

Authors:  Caleigh Mandel-Brehm; Leslie A Benson; Baouyen Tran; Mark P Gorman; Joseph L DeRisi; Andrew F Kung; Sabrina A Mann; Sara E Vazquez; Hanna Retallack; Hannah A Sample; Kelsey C Zorn; Lillian M Khan; Lauren M Kerr; Patrick L McAlpine; Lichao Zhang; Frank McCarthy; Joshua E Elias; Umakanth Katwa; Christina M Astley; Stuart Tomko; Josep Dalmau; William W Seeley; Samuel J Pleasure; Michael R Wilson
Journal:  Ann Neurol       Date:  2022-05-25       Impact factor: 11.274

9.  Rapid-Onset Obesity with Hypothalamic Dysfunction, Hypoventilation, and Autonomic Dysregulation (ROHHAD): exome sequencing of trios, monozygotic twins and tumours.

Authors:  Sarah F Barclay; Casey M Rand; Lauren A Borch; Lisa Nguyen; Paul A Gray; William T Gibson; Richard J A Wilson; Paul M K Gordon; Zaw Aung; Elizabeth M Berry-Kravis; Diego Ize-Ludlow; Debra E Weese-Mayer; N Torben Bech-Hansen
Journal:  Orphanet J Rare Dis       Date:  2015-08-25       Impact factor: 4.123

10.  Rapid-onset obesity, hypoventilation, hypothalamic dysfunction, autonomic dysregulation syndrome.

Authors:  Ismaeil Maksoud; Lina Kassab
Journal:  Avicenna J Med       Date:  2015 Jul-Sep
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.